drugset / Trial / NCT05555017
Tracer-Guided Surgery for Recurrent Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
ADT with or without robot-assisted PSMA-radioguided surgery for patients with recurrent prostate cancer.
Timeline
- Start
- 2023-02-15
- Primary completion
- 2024-11
- Completion
- 2025-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Background | Triptorelin | Other / unclassified | 22.5 mg | Subcutaneous |